These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9499184)

  • 1. Adjuvant chemotherapy with oral tegaful and uracil for maxillary sinus carcinoma.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J; Inuyama Y
    Oncology; 1998; 55(2):109-15. PubMed ID: 9499184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UFT plus carboplatin for head and neck cancer.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Tomita T; Yamashita T
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):72-5. PubMed ID: 11098499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
    Tsukuda M; Ogasawara H; Kaneko S; Komiyama S; Horiuchi M; Inuyama Y; Uemura T; Uchida M; Kamata S; Okuda M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1169-77. PubMed ID: 8031158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
    Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
    Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
    Wada H; Tanaka F; Hitomi S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
    Kato T; Ohashi Y; Nakazato H; Koike A; Saji S; Suzuki H; Takagi H; Nimura Y; Hasumi A; Baba S; Manabe T; Maruta M; Miura K; Yamaguchi A
    Langenbecks Arch Surg; 2002 Mar; 386(8):575-81. PubMed ID: 11914933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    Hasegawa K; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Watanabe T; Makuuchi M; Kokudo N
    PLoS One; 2016; 11(9):e0162400. PubMed ID: 27588959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uracil-tegafur in gastric carcinoma: a comprehensive review.
    Takiuchi H; Ajani JA
    J Clin Oncol; 1998 Aug; 16(8):2877-85. PubMed ID: 9704742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Ikeda K; Saitoh S; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
    Am J Clin Oncol; 1995 Jun; 18(3):204-10. PubMed ID: 7747707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
    Iwasaki K; Oida I; Usami A; Hashimoto Y; Yamada M; Ozawa T
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):369-72. PubMed ID: 10065103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
    J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
    Tanaka F; Yanagihara K; Otake Y; Miyahara R; Wada H
    Cancer Sci; 2004 Apr; 95(4):371-6. PubMed ID: 15072598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case in which palatal squamous cell carcinoma responded to UFT therapy].
    Matsumoto T; Teramura C; Iida S; Tanaka A; Ashida H; Kimura J
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):523-5. PubMed ID: 10097750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.